Literature DB >> 18036218

Brucella bacteremia in patients with acute leukemia: a case series.

Khalid Ahmed Al-Anazi1, Asma Marzouq Al-Jasser.   

Abstract

BACKGROUND: Brucellosis may cause serious infections in healthy individuals living in countries that are endemic for the infection. However, reports of brucella infections in immunocompromised hosts are relatively rare. CASE PRESENTATIONS: Reported here are two patients with acute leukemia who developed Brucella melitensis bacteremia during their follow up at the Armed Forces Hospital in Riyadh. The first patient developed B. melitensis bacteremia during the transformation of his myelodysplasia into acute myeloid leukemia. The second patient developed B. melitensis bacteremia while his acute lymphoblastic leukemia was under control. Interestingly, he presented with acute cholecystitis during the brucella sepsis. Both brucella infections were associated with a marked reduction in the hematological parameters in addition to other complications. The bacteremic episodes were successfully treated with netilmicin, doxycycline and ciprofloxacin.
CONCLUSION: Brucellosis can cause systemic infections, complicated bacteremia and serious morbidity in patients with acute leukemia living in endemic areas. These infections may occur at the presentation of the leukemia or even when the leukemia is in remission. Nevertheless, the early diagnosis of brucellosis and the administration of appropriate antimicrobial therapy for sufficient duration usually improves the outcome in these immunocompromised patients.

Entities:  

Year:  2007        PMID: 18036218      PMCID: PMC2174500          DOI: 10.1186/1752-1947-1-144

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


  14 in total

1.  Diagnostic value of Brucella ELISA IgG and IgM in bacteremic and non-bacteremic patients with brucellosis.

Authors:  A O Osoba; H Balkhy; Z Memish; M Y Khan; A Al-Thagafi; B Al Shareef; A Al Mowallad; G A Oni
Journal:  J Chemother       Date:  2001-04       Impact factor: 1.714

Review 2.  The new global map of human brucellosis.

Authors:  Georgios Pappas; Photini Papadimitriou; Nikolaos Akritidis; Leonidas Christou; Epameinondas V Tsianos
Journal:  Lancet Infect Dis       Date:  2006-02       Impact factor: 25.071

3.  Brucella melitensis in blood cultures of two newborns due to exchange transfusion.

Authors:  Mustafa Akçakuş; Duygu Esel; Neşide Cetin; Ayşenur Paç Kisaarslan; Selim Kurtoğlu
Journal:  Turk J Pediatr       Date:  2005 Jul-Sep       Impact factor: 0.552

4.  [Brucellosis with fatal endotoxic shock].

Authors:  S Kress; P Klooker; V Kaufmann; N Sloot; J F Riemann; H Brass
Journal:  Med Klin (Munich)       Date:  1997-09-15

5.  Clinical pattern and abdominal sonographic findings in 251 cases of brucellosis in southern Turkey.

Authors:  Mir Ali Pourbagher; Aysin Pourbagher; Lutfu Savas; Tuba Turunc; Yusuf Ziya Demiroglu; Ilknur Erol; Defne Yalcintas
Journal:  AJR Am J Roentgenol       Date:  2006-08       Impact factor: 3.959

6.  Brucella bacteraemia: clinical and laboratory observations in 160 patients.

Authors:  Z Memish; M W Mah; S Al Mahmoud; M Al Shaalan; M Y Khan
Journal:  J Infect       Date:  2000-01       Impact factor: 6.072

7.  Brucellosis in the etiology of febrile neutropenia: case report.

Authors:  R Sari; N Buyukberber; A Sevinc; Y Bayindir; S Buyukberber
Journal:  J Chemother       Date:  2002-02       Impact factor: 1.714

8.  Hematologic changes in brucellosis.

Authors:  E Crosby; L Llosa; M Miro Quesada; C Carrillo; E Gotuzzo
Journal:  J Infect Dis       Date:  1984-09       Impact factor: 5.226

9.  Microangiopathic hemolytic anemia and severe thrombocytopenia in Brucella infection.

Authors:  A Di Mario; S Sica; G Zini; P Salutari; G Leone
Journal:  Ann Hematol       Date:  1995-01       Impact factor: 3.673

10.  Acute lymphoblastic leukemia associated with brucellosis in two patients with fever and pancytopenia.

Authors:  Bulent Eser; Fevzi Altuntas; Isin Soyuer; Ozlem Er; Ozlem Canoz; Hasan Senol Coskun; Mustafa Cetin; Ali Unal
Journal:  Yonsei Med J       Date:  2006-10-31       Impact factor: 2.759

View more
  8 in total

1.  Brucella abortus Causing Febrile Neutropenia Together with Epididymoorchitis.

Authors:  Tuba Kasap; Serhan Küpeli
Journal:  Indian J Pediatr       Date:  2016-05-13       Impact factor: 1.967

2.  Brucellosis: a rare cause of febrile neutropenia in acute myeloblastic leukemia.

Authors:  Demircan Ozbalci; Ulku Ergene; Cigdem Banu Cetin
Journal:  Med Oncol       Date:  2010-02-19       Impact factor: 3.064

3.  A prospective study of brucellosis in children: relative frequency of pancytopenia.

Authors:  Mohamad A El-Koumi; Mona Afify; Salha H Al-Zahrani
Journal:  Iran J Pediatr       Date:  2014-04       Impact factor: 0.364

4.  Prevalence of brucellosis among patients attending Wau Hospital, South Sudan.

Authors:  Nuol Aywel Madut; George William Nasinyama; John Bwalya Muma; Kenneth L L Sube; Moses Ocan; Adrian Muwonge; Jacques Godfroid; Ambrose Samuel Jubara; Clovice Kankya
Journal:  PLoS One       Date:  2018-06-27       Impact factor: 3.240

5.  Brucella bacteremia in a recipient of an allogeneic hematopoietic stem cell transplant: a case report.

Authors:  Khalid A Al-Anazi; Saleh Abu Jafar; Asma M Al-Jasser; Hamad Al-Omar; Fahad I Al-Mohareb
Journal:  Cases J       Date:  2009-01-27

6.  A prospective study of brucellosis in children: relative frequency of pancytopenia.

Authors:  Mohamed A El-Koumi; Mona Afify; Salha H Al-Zahrani
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-02-16       Impact factor: 2.576

7.  Seroprevalence of Brucellosis in Human Immunodeficiency Virus Infected Patients in Hamadan, Iran.

Authors:  Fariba Keramat; Mohammad Mehdi Majzobi; Jalal Poorolajal; Zohreh Zarei Ghane; Maryam Adabi
Journal:  Osong Public Health Res Perspect       Date:  2017-08-31

8.  A case of brucellosis concomitant with HIV infection in China.

Authors:  Shuai-Bing Dong; Li-Ping Wang; Chao-Xue Wu; Fan Li; Yong Yue; Dong-Ri Piao; Hong-Yan Zhao; Hai Jiang
Journal:  Infect Dis Poverty       Date:  2020-01-16       Impact factor: 4.520

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.